Second primary malignancies in thyroid cancer patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akslen LA, Glattre E (1992) Second malignancies in thyroid cancer patients: a population-based survey of 3658 cases from Norway. Eur J Cancer 28: 491–495
Benhamou E, Laplanche A, Wartelle M, Faivre J, Gignoux M, Robillard J, Schraub S, Flamant R (1990) Incidence des cancers en France 1978–1982. Paris, France: Les éditions INSERM
Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II—The design and analysis of cohort studies. IARC Sci Publ Chapter 4, 120–174
Cancer Incidence in Sweden 1999 (2000) National Board of Health and Wellfare
Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R (2001) The development of breast carcinoma in women with thyroid carcinoma. Cancer 92: 225–231
Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Linos D, Negri E (2000) A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 11: 137–144
de Vathaire F, Koscielny S, Rezvani A, Laplanche A, Estève J, Ferlay J (1996) Estimation de l'incidence des cancers en France: période 1983–1987. Paris, France: Les Editions INSERM
de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H (1997) Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75: 734–739
Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L (1995) Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 36: 21–27
Edhemovic I, Volk N, Auersperg M (1998) Second primary cancers following thyroid cancer in Slovenia. A population-based cohort study. Eur J Cancer 34: 1813–1814
Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P (1999) Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353: 2111–2115
Hall P, Holm LE, Lundell G (1990) Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol 29: 869–873
Hall P, Holm LE, Lundell G, Bjelkengren G, Larsson LG, Lindberg S, Tennvall J, Wicklund H, Boice Jr JD (1991) Cancer risks in thyroid cancer patients. Br J Cancer 64: 159–163
Hall P, Holm LE, Lundell G, Ruden BI (1992) Tumors after radiotherapy for thyroid cancer. A case–control study within a cohort of thyroid cancer patients. Acta Oncol 31: 403–407
Hall P, Mattsson A, Boice Jr JD (1996) Thyroid cancer after diagnostic administration of iodine-131. Radiat Res 145: 86–92
Hammami MM, Bakheet S (1996) Radioiodine breast uptake in nonbreastfeeding women: clinical and scintigraphic characteristics. J Nucl Med 37: 26–31
Horn-Ross PL, Morris JS, Lee M, West DW, Whittemore AS, McDougall IR, Nowels K, Stewart SL, Spate VL, Shiau AC, Krone MR (2001) Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 10: 979–985
International Commission on Radiological Protection (ICRP) (1988) Radiation Dose to Patients from Radiopharmaceuticals. ICRP publication 53,Oxford: Pergamon Press
Ishikawa K, Noguchi S, Tanaka K, Fukuda A, Hirohata T (1996) Second primary neoplasms in thyroid cancer patients. Jpn J Cancer Res 87: 232–239
La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Lund E, Levi F, Linos D, Negri E (1999) A pooled analysis of case–control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10: 157–166
Li CI, Rossing MA, Voigt LF, Daling JR (2000) Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States). Cancer Causes Control 11: 805–811
Lindor NM, Greene MH (1998) The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 90: 1039–1071
M'Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N, Parmentier C (1996) Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 37: 1860–1864
Menegoz F, Cherié-Challine L (2000) Le Cancer en France: Incidence et Mortalité. Situation en 1995. Evolution entre 1975 et 1995. Réseau FRANCIM
Moolgavkar SH, Venzon DJ (1987) A method for computing profile likelihood-based confidence bounds. Ann Statist 15: 346–359
Muir C, Waterhouse J, Mack T, Whelan S (1987) Cancer Incidence in Five Continents, vol V. Lyon: International Agency for Research on Cancer
Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, McTiernan A, Kolonel L, Yoshimoto Y, Jin F, Wingren G, Rosaria GM, Hardell L, Glattre E, Lund E, Levi F, Linos D, Braga C, Franceschi S (1999) A pooled analysis of case–control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10: 143–155
Osterlind A, Olsen JH, Lynge E, Ewertz M (1985) Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943–80. Natl Cancer Inst Monogr 68: 361–388
Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (1992) Cancer Incidence in Five Continents, Vol. VI. Lyon: IARC Scientific publications No. 12
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer Incidence in Five Continents, Vol. VII. Lyon: IARC Scientific publications No. 143
Preston DL, Lubin JH, Pierce DA, McConney ME (1991) EPICURE. Generalized Regression Models for Epidemiological Data. Seattle, WA: Hirosoft International Corporation
Ron E, Curtis R, Hoffman DA, Flannery JT (1984) Multiple primary breast and thyroid cancer. Br J Cancer 49: 87–92
Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris III BS, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice Jr JD (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280: 347–355
Shikhani AH, Matanoski GM, Jones MM, Kashima HK, Johns ME (1986) Multiple primary malignancies in head and neck cancer. Arch Otolaryngol Head Neck Surg 112: 1172–1179
Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T (1997) Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82: 2037–2043
Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6: 871–878
Teppo L, Pukkala E, Saxen E (1985) Multiple cancer – an epidemiologic exercise in Finland. J Natl Cancer Inst 75: 207–217
Tucker MA, Boice Jr JD, Hoffman DA (1985) Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82. Natl Cancer Inst Monogr 68: 161–189
UNSCEAR (2000) Sources and Effects of Ionizing Radiation. New-York, NY, USA: United Nations